Merilog, classified as a rapid-acting human insulin analog, is designed to reduce mealtime blood sugar spikes, improving blood sugar management for adults and pediatric diabetes patients.

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.

studies conducted with non-commercially available analog formulations, or trials conducted with insulin preparations that are no longer commercially available.

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

Click here to read the article now. TI has a more rapid onset of action than rapid-acting insulin analogues. In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin ...

Objectives: The prevalence, causes, and consequences of nocturnal hypoglycemia as well as detection and prevention strategies are reviewed, including the use of long-acting insulin analogs ...